Indian rupee was little changed against US dollar on Thursday amid eased concerns over the impact of the new COVID variant on the economy after drug makers BioNTech and Pfizer said a three-shot course of their Covid-19 vaccine was found to neutralise the new Omicron variant in preliminary tests. Moreover, the Indian central bank RBI kept borrowing costs at a record-low for the ninth consecutive time on Wednesday to continue supporting economic growth amid worries around the Omicron corona-virus variant. However, subdued domestic equities amid unabated foreign fund outflows and firm American currency have pressurising rupee sentiments and capped further gains. Foreign institutional investors (FIIs) were net sellers in the capital market as they offloaded shares worth Rs 579.27 crore on Wednesday, exchange data showed.
The partially convertible currency is currently trading at 75.49, little changed by 1 paise from its previous close of 75.50 on Wednesday. The currency touched a high and low of 75.5300 and 75.4500 respectively.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: